STOCKS | Definium Therapeutics Surges as Much as 60% on Late-Stage Depression Drug Trial Results
2026-06-22 17:26:12
Definium Therapeutics Inc. shares rallied as much as 60% Monday after late-stage trial data showed “groundbreaking” results for the psychedelic drugmaker’s experimental treatment for major depressive disorders, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
股票市场 | Definium因抑郁症药物成功大涨
